Literature DB >> 33834449

The Application of Mass Spectrometry in Drug Metabolism and Pharmacokinetics.

Ji-Yoon Lee1, Sang Kyum Kim2, Kiho Lee3, Soo Jin Oh4,5.   

Abstract

Drug metabolism and pharmacokinetics (DMPK) are fundamental in drug discovery. New chemical entities (NCEs) are typically evaluated with various in vitro and in vivo assays, which are time-consuming and labor intensive. These experiments are essential in identifying potential new drugs. Recently, mass spectrometry (MS) has played a key role in examining the drug-like properties of NCEs. Quantitative and qualitative mass spectrometry approaches are routinely utilized to obtain high-quality data in an efficient, timely, and cost-effective manner. Especially, liquid chromatography (LC) coupled with MS technology has been refined for metabolite identification (Met ID), which is critical for lead optimization. These qualitative and quantitative MS approaches and their specific utility in DMPK characterization will be described in this chapter.

Entities:  

Keywords:  Drug discovery; Drug metabolism; Mass spectrometry; Pharmacokinetics

Mesh:

Substances:

Year:  2021        PMID: 33834449     DOI: 10.1007/978-981-33-6064-8_20

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  59 in total

Review 1.  Utility of mass spectrometry for in-vitro ADME assays.

Authors:  Inhou Chu; Amin A Nomeir
Journal:  Curr Drug Metab       Date:  2006-06       Impact factor: 3.731

Review 2.  Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

Authors:  Paweł Baranczewski; Andrzej Stańczak; Kathrin Sundberg; Richard Svensson; Asa Wallin; Jenny Jansson; Per Garberg; Hans Postlind
Journal:  Pharmacol Rep       Date:  2006 Jul-Aug       Impact factor: 3.024

3.  An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes.

Authors:  Loren M Berry; Zhiyang Zhao
Journal:  Drug Metab Lett       Date:  2008-01

4.  Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin.

Authors:  Sebastien Bolze; Norbert Bromet; Croisine Gay-Feutry; Frederic Massiere; Roselyne Boulieu; Thierry Hulot
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

Review 5.  Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.

Authors:  Caroline Bylda; Roland Thiele; Uwe Kobold; Dietrich A Volmer
Journal:  Analyst       Date:  2014-05-21       Impact factor: 4.616

Review 6.  Atmospheric pressure chemical ionization mass spectrometry for analysis of lipids.

Authors:  W C Byrdwell
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

Review 7.  Predictability of the covalent binding of acidic drugs in man.

Authors:  L Z Benet; H Spahn-Langguth; S Iwakawa; C Volland; T Mizuma; S Mayer; E Mutschler; E T Lin
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

Review 8.  Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions.

Authors:  Urs A Boelsterli
Journal:  Curr Drug Metab       Date:  2002-08       Impact factor: 3.731

Review 9.  Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology.

Authors:  U A Boelsterli; H J Zimmerman; A Kretz-Rommel
Journal:  Crit Rev Toxicol       Date:  1995       Impact factor: 5.635

10.  Qualitative and Quantitative Analysis of the Major Constituents in Shexiang Tongxin Dropping Pill by HPLC-Q-TOF-MS/MS and UPLC-QqQ-MS/MS.

Authors:  Daxin Chen; Shan Lin; Wen Xu; Mingqing Huang; Jianfeng Chu; Fei Xiao; Jiumao Lin; Jun Peng
Journal:  Molecules       Date:  2015-10-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.